Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Mendelsohn_2004_Int.Clin.Psychopharmacol_19_319

Reference

Title: Rivastigmine augmentation in the management of chronic schizophrenia with comorbid dementia: an open-label study investigating effects on cognition, behaviour and activities of daily living
Mendelsohn E, Rosenthal M, Bohiri Y, Werber E, Kotler M, Strous RD
Ref: Int Clin Psychopharmacol, 19:319, 2004 : PubMed

        



Related information



Citations formats

Mendelsohn E, Rosenthal M, Bohiri Y, Werber E, Kotler M, Strous RD (2004)
Rivastigmine augmentation in the management of chronic schizophrenia with comorbid dementia: an open-label study investigating effects on cognition, behaviour and activities of daily living
Int Clin Psychopharmacol 19: 319-24

Mendelsohn E, Rosenthal M, Bohiri Y, Werber E, Kotler M, Strous RD (2004)
Int Clin Psychopharmacol 19: 319-24



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer